Cited by 142Inflammatory Bowel DiseaseAdolescent and Pediatric HealthcareMental Health Treatment and Access

Increased Risks of Developing Anxiety and Depression in Young Patients With Crohn's Disease

Open access
Loftus, Edward V, Guérin, Annie, Yu, Andrew P, Wu, Eric Q, Yang, Mei, Chao, Jingdong, Mulani, Parvez M·2011·American Journal of Gastroenterology

Abstract

OBJECTIVES: Crohn's disease (CD) is associated with substantial psychosocial burden and increased risks for mental health disorders. This retrospective cohort study compared the risks of developing anxiety disorders and depression and incidences of psychotropic medication use between young CD patients and matched CD-free controls. METHODS: Medical claims, prescription drug claims, enrollment, and demographic data for patients <18 years diagnosed with CD were obtained from the MarketScan database (1 January 2000-30 June 2006). Each CD patient was matched with five CD-free controls based on exact age, sex, and months of health plan enrollment. Incidence rates and risks of developing anxiety disorders and depression and psychotropic medication use in the 6 months after the index date were compared, as were risks of developing persistent anxiety or depression (receiving medical services related to a diagnosis of anxiety or depression or psychotropic therapy for >1 year). RESULTS: After adjustment for patient characteristics, the risks of developing anxiety disorders (hazard ratio (HR) [95% confidence interval (CI);[equals;2.28 [1.65-3.17]) and depression (HR [95% CI;[equals;1.74 [1.35-2.25]) after CD diagnosis were significantly greater for the CD cohort (N=2,144) than for CD-free controls (N=10,720). Patients with CD also had greater risks of developing persistent anxiety and persistent depression (HR [95% CI;[equals;4.35 [2.22-8.50] and 2.75 [1.73-4.38], respectively). CONCLUSIONS: Compared with matched CD-free controls, young patients with CD had significantly greater risks of developing anxiety disorders and depression, were more likely to receive psychotropic treatments, and had significantly greater risks of developing persistent anxiety and depression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ajg.2011.142

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Loftus, E. V., Guérin, A., Yu, A. P., Wu, E. Q., Yang, M., Chao, J., & Mulani, P. M.
Affiliations
  • Mayo Clinic (US)
  • Analysis Group (United States) (US)
Corresponding author
Loftus, Edward V
Venue
American Journal of Gastroenterology
Published
2011-09
Volume
106
Issue
9
Pages
1670-1677
ISSN
0002-9270 (ISSN-L)
OpenAlex
W2106480963
Cited by
142
References
45
Citations by year
2026: 4 · 2025: 8 · 2024: 7 · 2023: 8 · 2022: 10 · 2021: 5 · 2020: 16 · 2019: 11 · 2018: 13 · 2017: 10 · 2016: 14 · 2015: 9 · 2014: 12 · 2013: 14 · 2012: 1
FWCI
5.38
Type
journal article
Language
en
Open access
Locations
  • The American Journal of Gastroenterology (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
Funders
  • Otsuka America
  • ActoGeniX
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Health Sciences › Health Professions › Speech and Hearing › Adolescent and Pediatric Healthcare
  • Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
Keywords
Crohn's disease, anxiety disorders, depression, psychotropic drug use, young patients, persistent anxiety, dysthymia, mental health risk, psychosocial burden
MeSH terms
Adolescent, Adrenal Cortex Hormones, Age Factors, Antidepressive Agents, Anxiety, Anxiety Disorders, Child, Child, Preschool, Crohn Disease, Depression, Depressive Disorder, Female, Humans, Infant, Insurance, Health, Male, Retrospective Studies, Risk Factors, Sex Factors, Antipsychotic Agents, Anti-Anxiety Agents, Incidence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review